Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping and restarting Mounjaro for weight loss is something many people need to do — whether because of a surgery, supply issues, a planned break, or a side effect that gets too uncomfortable. Weight that was lost often starts to return once the medicine is stopped, usually within weeks, because Mounjaro works while it is in your system. When you restart, your prescriber will typically guide you back to a lower dose first, to let your body readjust. These are prescription-only medicines, so any decision to stop, pause or restart should be made with your prescribing clinician rather than alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) works by activating two gut-hormone receptors that reduce appetite and slow gastric emptying. Once you stop injecting, those effects wind down over the following days. For most people, hunger returns gradually, portion sizes creep back, and the body (which has strong biological mechanisms to defend its previous weight) begins to regain.
This pattern is well recognised in clinical research. In trials of GLP-1 and dual GIP/GLP-1 medicines, participants who stopped treatment after the active phase regained a substantial portion of lost weight over the following year, even when they continued lifestyle changes. The NHS medicines page for tirzepatide notes that treatment is intended to be ongoing alongside a reduced-calorie diet and increased activity, the implication being that stopping removes a significant part of the mechanism supporting weight management.
That is not a reason to feel disheartened if you have had to pause. It is, though, a reason to have a clear plan. If you are thinking about stopping Mounjaro (whether by choice or necessity) knowing what to expect makes the gap easier to manage. Keep an eye on your hunger signals in the first two to three weeks; that is one of the earliest signs the medicine has cleared your system, and it costs you nothing to notice it.
It does, in a couple of ways. First, the length of the gap matters practically. A break of one or two weeks (the kind caused by a delivery delay or a short hospital admission) is generally handled differently from a gap of several months. After a short pause, your prescriber may advise resuming at the same dose with close monitoring. After a longer break, you would almost certainly step back to a lower dose, the way you did when starting originally, to avoid the nausea and GI discomfort that a high dose can cause on a system that has lost its tolerance.
Second, the reason itself can affect suitability. If you stopped because of a persistent side effect (say, vomiting that would not settle) your prescriber needs to know that before deciding whether restarting at a lower dose is appropriate, or whether a different approach makes more sense. If you stopped for surgery, the anaesthetic team would have asked you to pause for a specific period, and your prescriber will want to confirm the procedure has healed well before you resume. The guidance on timing for surgical pauses is covered in more detail on our restarting Mounjaro page.
People also sometimes stop because weight loss stalled. If that is your situation, it is worth reading about why weight loss on Mounjaro can plateau before assuming a break and restart will resolve things, often, there are adjustments that do not require stopping at all.
Tirzepatide is licensed in the UK in six strengths (2.5, 5, 7.5, 10, 12.5 and 15 mg) with treatment beginning at 2.5 mg as a tolerability dose. The body adapts to each step before moving to the next, typically across four-week intervals directed by the prescriber. After a long break, that tolerance is gone.
Most prescribers would restart from 2.5 mg and move through the schedule again, though the pace can sometimes be a little faster if you tolerated the higher doses well previously. Your prescriber sets that pace based on how you are responding, it is not a fixed rule but a clinical judgement. The NICE technology appraisal for tirzepatide (TA1026) provides the framework within which prescribers operate, including the expectation that treatment is reviewed if progress is insufficient.
For shorter breaks (specifically if you have missed two or three weeks) there is specific guidance worth reading before you inject again. Our pages on restarting after two weeks and restarting after three weeks cover those scenarios with the relevant clinical detail. The short version: do not simply inject the dose you were on without checking with your prescriber first.
Lifestyle measures do help, even if they cannot fully replace the medicine's effect. Prioritising protein at meals, staying well hydrated, and keeping some form of regular movement going are the foundations. These are not about willpower; they are about giving the body the best environment while the hormonal support is absent.
Some people find that a planned break (agreed in advance with their prescriber, with a clear restart date) is easier to manage than an unplanned one, because the expectation is already set. If you went into the pause knowing hunger would return, it is less alarming when it does.
If you are considering treatment for the first time rather than returning to it, our guide to starting Mounjaro covers what the first few weeks look like from scratch. For a broader picture of how tirzepatide works and who it is licensed for, the tirzepatide overview is a good starting point. And if cost is a factor in whether you continue (a question many people have) the Mounjaro cost page sets out what private treatment involves without hiding the numbers.
If you would like a prescriber to review your situation (whether you are mid-break, considering stopping, or ready to restart) you are welcome to check your eligibility with our clinical team. Every review at nume is carried out by a real GPhC-registered prescriber, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.